m6A-centered Disease Response Information
General Information of the Disease (ID: M6ADIS0130)
Name |
Male reproductive disorders
|
||||
---|---|---|---|---|---|
ICD |
ICD-11: VV5Z
|
Full List of Target Gene(s) of This m6A-centered Disease Response
Nuclear factor erythroid 2-related factor 2 (NFE2L2)
In total 2 item(s) under this target gene | ||||
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | DEHP worsened testicular histology, decreased testosterone concentrations, downregulated expression of spermatogenesis inducers, enhanced oxidative stress, inhibited the Nuclear factor erythroid 2-related factor 2 (NFE2L2)-mediated antioxidant pathway, and increased apoptosis in testes. DEHP is a common environmental endocrine disrupting chemical that induces male reproductive disorders. Additionally, DEHP increased global levels of m6A RNA modification and altered the expression of two important RNA methylation modulator genes, FTO and YTHDC2. | |||
Responsed Disease | Male reproductive disorders [ICD-11: VV5Z] | |||
Target Regulator | Fat mass and obesity-associated protein (FTO) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Oxidative stress | |||
Cell apoptosis | ||||
In-vivo Model | Exposed Sprague-Dawley rats to 0, 250, and 500 mg DEHP per kg body weight per day at the prepuberty stage from postnatal day 22 (PND 22) to PND 35 by oral gavage. | |||
Experiment 2 Reporting the m6A-centered Disease Response by This Target Gene | [1] | |||
Response Summary | DEHP worsened testicular histology, decreased testosterone concentrations, downregulated expression of spermatogenesis inducers, enhanced oxidative stress, inhibited the Nuclear factor erythroid 2-related factor 2 (NFE2L2)-mediated antioxidant pathway, and increased apoptosis in testes. DEHP is a common environmental endocrine disrupting chemical that induces male reproductive disorders. Additionally, DEHP increased global levels of m6A RNA modification and altered the expression of two important RNA methylation modulator genes, FTO and YTHDC2. | |||
Responsed Disease | Male reproductive disorders [ICD-11: VV5Z] | |||
Target Regulator | YTH domain-containing protein 2 (YTHDC2) | READER | ||
Cell Process | Oxidative stress | |||
Cell apoptosis | ||||
In-vivo Model | Exposed Sprague-Dawley rats to 0, 250, and 500 mg DEHP per kg body weight per day at the prepuberty stage from postnatal day 22 (PND 22) to PND 35 by oral gavage. | |||